Canterbury AI was founded in 2019 by a group of entrepreneurial professionals. We are members of Kent Invicta Chamber of Commerce, The Federation of Small Businesses, and The Commonwealth Business Club.
Canterbury AI offers powered solutions that deliver maximum value for your business no matter what industry you are in we can develop software for you. Canterbury AI aligns with your overall business strategy, supporting you to prioritize what you need and when. We offer solutions that are configured to meet your needs, with each one focused on optimizing specific business functions.
Wesley Baker has been involved in businesses from Medical Device, Tourism, Software, Airlines, Manufacturing, Business Incubation, Lifestyle, Innovation Technology and Space Technology. He is British and started his first business software venture at 14. He has founded and been CEO of businesses across a range of industries. He has appeared on TV and Radio and in other printed media. Wesley has a range of experience covering Strategy and Business Development, Marketing, and Raising Investment Funds as well as developing new exciting opportunities from start. Wesley is a senior associate member of the Royal Society of Medicine and a Member of the Institute of Directors.
Dan Luo is a Medical Ophthalmologist doctor where her routine work included clinical, emergency work with other Ophthalmologist in a team on treatments and operations for patients. Dr Luo concentrated on corneitis, ocular tumour, cataract, glaucoma, uveitis, macular degeneration, retinal detachment, diabetic retinopathy, an ocular complication of other system diseases. This experience is crucial for Canterbury AI as it offers the company a field of medical expertise that will be critical moving forward. Dr Luo later in her career then concentrated on many forms of Medical research involved with the identification of diseases and methods of the process a vital element needed within the new business – it is her vision and her perception to start this business in the UK so as to benefit from the cutting edge advancements in AI and ML development within the medical arena.